Who Supplies Gemcitabine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Gemcitabine exports, with 248+ registered manufacturers shipping to buyers across 125+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 10.0% (export value: $4.6M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (6.1%, $2.8M). FRESENIUS KABI ONCOLOGY LIMITED (6.0%, $2.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Gemcitabine? Top Manufacturers & Their Buyers
Flow of Gemcitabine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Gemcitabine Supplier Network — Key Market Intelligence
The Gemcitabine export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 10.0% share, shipping $4.6M worth of product across 137 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $2.8M (6.1%) to the overall market. Combined, the top two suppliers alone account for 16.0% of all Gemcitabine exports, indicating a relatively concentrated supply base.
Across all 248 tracked manufacturers, the total Gemcitabine export value stands at $46.5M from 2.9K shipments. The market average shipment value is $15.8K. The single largest buyer relationship in terms of trade value is YUSEN LOGISTICS BENELUX BELGIUM, receiving $4.0M worth of product.
The combined buyer network spans 20 named purchasing companies, including YUSEN LOGISTICS BENELUX BELGIUM, KEETBERGLAAN 2, M/S. SUN PHARMACEUTI, SUN PHARMACEUTICALS , EUGIA PHARMA (MALTA) LTD, and 15 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Gemcitabine exporter from India, with a market share of 10.0% and a total export value of $4.6M across 137 shipments. Their average shipment value of $33.9K is above the market average of $15.8K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 85.6% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $4.0M across 117 shipments (85.6% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $351.3K across 10 shipments (7.6% of this supplier's total exports)
• KEETBERGLAAN 2 — $141.1K across 4 shipments (3.0% of this supplier's total exports)
• M/S. SUN PHARMACEUTI — $130.9K across 4 shipments (2.8% of this supplier's total exports)
• SUN PHARMACEUTICALS — $44.9K across 1 shipments (1.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $33.9K is 114% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Gemcitabine exporter from India, with a market share of 6.1% and a total export value of $2.8M across 188 shipments. Their average shipment value of $15.0K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EUGIA PHARMA (MALTA) LTD, — $1.1M across 73 shipments (39.1% of this supplier's total exports)
• APL SWIFT SERVICES (MALTA) LTD., — $631.4K across 42 shipments (22.4% of this supplier's total exports)
• EUGIA PHARMA MALTA L — $380.2K across 25 shipments (13.5% of this supplier's total exports)
• AUROVIDA FARMACEUTIC — $366.4K across 24 shipments (13.0% of this supplier's total exports)
• APL SWIFT SERVICES (MALTA) LTD., — $342.6K across 23 shipments (12.1% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED operates with high shipment frequency (188 shipments) at a per-shipment value of $15.0K, indicating a broad distribution network with many smaller, regular orders.
3FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the third-largest Gemcitabine exporter from India, with a market share of 6.0% and a total export value of $2.8M across 339 shipments. Their average shipment value of $8.2K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FRESENIUS KABI DEUTSCHLAND GMBH — $1.2M across 142 shipments (42.0% of this supplier's total exports)
• FRESENIUS KABI (THAILAND) LTD — $495.5K across 61 shipments (17.9% of this supplier's total exports)
• FRESENIUS KABI THAIL — $408.4K across 50 shipments (14.7% of this supplier's total exports)
• FRESENIUS KABI (THAILAND) LTD — $370.1K across 45 shipments (13.3% of this supplier's total exports)
• FRESENIUS KABI MALAYSIA SDN BHD — $334.9K across 41 shipments (12.1% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (339 shipments) at a per-shipment value of $8.2K, indicating a broad distribution network with many smaller, regular orders.
4MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fourth-largest Gemcitabine exporter from India, with a market share of 5.8% and a total export value of $2.7M across 32 shipments. Their average shipment value of $85.0K is above the market average of $15.8K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 2 named buyers in our database. MYLAN INSTITUTIONAL INC is the dominant customer, accounting for 54.1% of this supplier's tracked business. Top customers include:
• MYLAN INSTITUTIONAL INC — $1.5M across 17 shipments (54.1% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC — $1.2M across 15 shipments (45.9% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $85.0K is 437% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.
5ACCURE LABS PRIVATE LIMITED
ACCURE LABS PRIVATE LIMITED is the fifth-largest Gemcitabine exporter from India, with a market share of 5.8% and a total export value of $2.7M across 107 shipments. Their average shipment value of $25.2K is above the market average of $15.8K, suggesting premium or bulk contract pricing.
ACCURE LABS PRIVATE LIMITED serves 5 named buyers in our database. PHARMACIE CENTRALE DES HOPITAUX is the dominant customer, accounting for 65.1% of this supplier's tracked business. Top customers include:
• PHARMACIE CENTRALE DES HOPITAUX — $1.8M across 70 shipments (65.1% of this supplier's total exports)
• To The Order — $322.1K across 13 shipments (12.0% of this supplier's total exports)
• NA — $293.4K across 12 shipments (10.9% of this supplier's total exports)
• BANQUE POPULAIRE BPC — $178.2K across 7 shipments (6.6% of this supplier's total exports)
• CREDIT IMMOBILIER ET — $146.2K across 6 shipments (5.4% of this supplier's total exports)
Key Insight: ACCURE LABS PRIVATE LIMITED's per-shipment value of $25.2K is 59% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.
6INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Gemcitabine exporter from India, with a market share of 3.7% and a total export value of $1.7M across 231 shipments. Their average shipment value of $7.4K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES,LLC — $677.8K across 91 shipments (39.5% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES — $342.7K across 46 shipments (20.0% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES,LLC — $325.1K across 44 shipments (18.9% of this supplier's total exports)
• ACCORD HEALTHCARE C/ — $198.1K across 27 shipments (11.5% of this supplier's total exports)
• XXCORXXHEAXXHCAXX B — $173.8K across 23 shipments (10.1% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (231 shipments) at a per-shipment value of $7.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Gemcitabine Flows
Once Gemcitabine leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $46.5M. United States absorbs the largest share at 16.8% ($7.8M), followed by Belgium (12.7%) and Malta (11.6%).
In United States — the top destination — named importers include MYLAN INSTITUTIONAL INC 2898, MYLAN INSTITUTIONAL INC, EVERSANA LIFE SCIENCES SERVICES,LLC. In Belgium, key buyers are YUSEN LOGISTICS BENELUX BELGIUM.
This geographic spread reflects Gemcitabine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Gemcitabine Go? Top Importing Countries & Their Buyers
Trade flow of Gemcitabine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Gemcitabine imports from India, with a total trade value of $7.8M across 47 shipments — representing a 16.8% share of all Gemcitabine exports. The average shipment value of $166.1K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Gemcitabine importers in United States: MYLAN INSTITUTIONAL INC 2898 is the largest buyer, accounting for 31.5% ($2.5M) of this market's total imports.
• MYLAN INSTITUTIONAL INC 2898 — $2.5M (31.5% of United States's total)
• MYLAN INSTITUTIONAL INC — $1.2M (16.0% of United States's total)
• EVERSANA LIFE SCIENCES SERVICES,LLC — $946.8K (12.1% of United States's total)
Key Insight: United States's per-shipment average of $166.1K (949% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Gemcitabine imports from India.
2Belgium
Belgium ranks as the second-largest destination for Gemcitabine imports from India, with a total trade value of $5.9M across 116 shipments — representing a 12.7% share of all Gemcitabine exports. The average shipment value of $50.9K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Gemcitabine importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 85.9% ($5.1M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $5.1M (85.9% of Belgium's total)
Key Insight: Belgium's per-shipment average of $50.9K (221% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Gemcitabine imports from India.
3Malta
Malta ranks as the third-largest destination for Gemcitabine imports from India, with a total trade value of $5.4M across 142 shipments — representing a 11.6% share of all Gemcitabine exports. The average shipment value of $38.2K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Gemcitabine importers in Malta: EUGIA PHARMA (MALTA) LTD, is the largest buyer, accounting for 62.2% ($3.4M) of this market's total imports.
• EUGIA PHARMA (MALTA) LTD, — $3.4M (62.2% of Malta's total)
• APL SWIFT SERVICES (MALTA) LTD., — $631.4K (11.7% of Malta's total)
Key Insight: Malta's per-shipment average of $38.2K (141% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malta is a key market for Gemcitabine imports from India.
4Algeria
Algeria ranks as the fourth-largest destination for Gemcitabine imports from India, with a total trade value of $3.5M across 87 shipments — representing a 7.6% share of all Gemcitabine exports. The average shipment value of $40.6K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Gemcitabine importers in Algeria: PHARMACIE CENTRALE DES HOPITAUX is the largest buyer, accounting for 59.5% ($2.1M) of this market's total imports.
• PHARMACIE CENTRALE DES HOPITAUX — $2.1M (59.5% of Algeria's total)
• SPA IMGSA GROUPE INSDUSTRIES — $748.4K (21.2% of Algeria's total)
Key Insight: Algeria's per-shipment average of $40.6K (156% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Algeria is a key market for Gemcitabine imports from India.
5Russia
Russia ranks as the fifth-largest destination for Gemcitabine imports from India, with a total trade value of $2.9M across 23 shipments — representing a 6.3% share of all Gemcitabine exports. The average shipment value of $126.6K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Gemcitabine importers in Russia: OOO JODAS EXPOIM is the largest buyer, accounting for 40.9% ($1.2M) of this market's total imports.
• OOO JODAS EXPOIM — $1.2M (40.9% of Russia's total)
• OOOJODAS EXPOIM — $677.7K (23.3% of Russia's total)
• OOO"JODAS EXPOIM" — $481.1K (16.5% of Russia's total)
Key Insight: Russia's per-shipment average of $126.6K (699% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Gemcitabine imports from India.
People Also Ask — Gemcitabine Supplier & Trade Network
Who are the top suppliers of Gemcitabine from India?+
Which companies buy Gemcitabine from Indian manufacturers?+
Where does Gemcitabine exported from India go?+
What is the market share of the top Gemcitabine supplier from India?+
What is the average shipment value for Gemcitabine exports from India?+
Is Gemcitabine manufactured in India and exported globally?+
Which country imports the most Gemcitabine from India?+
Who are the buyers of Gemcitabine in Belgium?+
How concentrated is the Gemcitabine supplier market in India?+
How do I find verified buyers for Gemcitabine in specific countries?+
Gemcitabine Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Gemcitabine exporter with a 10.0% market share and $4.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 248 suppliers collectively account for 37.3% of all tracked Gemcitabine exports, with a combined trade value of $46.5M.
- 3United States is the largest destination market, absorbing 16.8% of India's Gemcitabine exports ($7.8M). Belgium (12.7%) and Malta (11.6%) follow.
- 4With 2.9K total shipments averaging $15.8K each, the Gemcitabine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM, EUGIA PHARMA (MALTA) LTD,, APL SWIFT SERVICES (MALTA) LTD., — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 125 countries
Network value: $46.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gemcitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Gemcitabine.
- 2.Flow Mapping: 248 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,938 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 125 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,938 Verified Shipments
248 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists